- Corporate Officers - W
- Wilson Troy Edward
Insider Trading History of Wilson Troy Edward
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wilson Troy Edward since 2017.
This trader's CIK number is 1589597.
At the time of last reporting, Wilson Troy Edward was the President and CEO of Kura Oncology, Inc.. (stock ticker symbol KURA).
Also see all insider trading activities at Kura Oncology, Inc..
Note that in the past
WILSON TROY EDWARD also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Avidity Biosciences, Inc. (RNA) by Wilson Troy Edward
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | RNA | 0 | $0 | 95,054 | $4,277,430 | 29,500 | $361,522 |
Yearly summary of insider trading at Puma Biotechnology, Inc. (PBYI) by Wilson Troy Edward
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | PBYI | 0 | $0 | 10,800 | $36,720 | 0 | $0 |
| 2024 | PBYI | 0 | $0 | 27,000 | $89,910 | 0 | $0 |
| 2023 | PBYI | 0 | $0 | 27,000 | $93,258 | 0 | $0 |
| 2022 | PBYI | 0 | $0 | 27,858 | $71,985 | 0 | $0 |
| 2021 | PBYI | 0 | $0 | 25,748 | $292,445 | 0 | $0 |
| 2020 | PBYI | 0 | $0 | 25,245 | $251,692 | 0 | $0 |
Yearly summary of insider trading at Kura Oncology, Inc. (KURA) by Wilson Troy Edward
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | KURA | 50,000 | $303,223 | 0 | $0 | 0 | $0 |
| 2024 | KURA | 0 | $0 | 91,052 | $1,841,981 | 91,052 | $498,509 |
| 2020 | KURA | 0 | $0 | 571,604 | $16,831,925 | 204,819 | $1,182,036 |
| 2018 | KURA | 0 | $0 | 0 | $0 | 26,041 | $124,996 |
| 2017 | KURA | 0 | $0 | 0 | $0 | 32,985 | $158,328 |
Insider trading activities at 3 companies by Wilson Troy Edward:
1. Avidity Biosciences, Inc. (RNA)
2. Puma Biotechnology, Inc. (PBYI)
3. Kura Oncology, Inc. (KURA)
Table 1. Insider trading of Avidity Biosciences, Inc. (RNA) by Wilson Troy Edward
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-06 | RNA | Sale | 95,054 | 45.00 | 4,277,430 |
| 2025-08-06 | RNA | Option Ex | 29,500 | 12.26 | 361,522 |
Table 2. Insider trading of Puma Biotechnology, Inc. (PBYI) by Wilson Troy Edward
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-13 | PBYI | Sale | 10,800 | 3.40 | 36,720 |
| 2024-06-13 | PBYI | Sale | 27,000 | 3.33 | 89,910 |
| 2023-06-13 | PBYI | Sale | 27,000 | 3.45 | 93,258 |
| 2022-06-16 | PBYI | Sale | 27,858 | 2.58 | 71,985 |
| 2021-06-10 | PBYI | Sale | 25,748 | 11.36 | 292,445 |
| 2020-06-11 | PBYI | Sale | 25,245 | 9.97 | 251,692 |
Table 3. Insider trading of Kura Oncology, Inc. (KURA) by Wilson Troy Edward
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-12 | KURA | Buy | 36,506 | 5.85 | 213,596 |
| 2025-08-13 | KURA | Buy | 13,494 | 6.64 | 89,627 |
| 2024-01-24 | KURA | Option Ex | 91,052 | 5.47 | 498,509 |
| 2024-01-24 | KURA | Sale | 91,052 | 20.23 | 1,841,981 |
| 2020-12-01 | KURA | Option Ex | 11,855 | 6.15 | 72,908 |
| 2020-10-07 | KURA | Option Ex | 4,586 | 6.15 | 28,203 |
| 2020-10-06 | KURA | Sale | 100 | 32.00 | 3,200 |
| 2020-10-08 | KURA | Option Ex | 50,370 | 6.15 | 309,775 |
| 2020-10-07 | KURA | Sale | 104,486 | 33.00 | 3,448,038 |
| 2020-10-08 | KURA | Sale | 157,106 | 34.00 | 5,341,604 |
| 2020-09-14 | KURA | Sale | 98,490 | 28.82 | 2,838,875 |
| 2020-09-11 | KURA | Option Ex | 17,926 | 6.15 | 110,244 |
| 2020-09-11 | KURA | Sale | 18,411 | 28.00 | 515,508 |
| 2020-09-10 | KURA | Option Ex | 37,030 | 6.15 | 227,734 |
| 2020-09-08 | KURA | Sale | 50,000 | 26.00 | 1,300,000 |
| 2020-09-10 | KURA | Sale | 38,055 | 28.00 | 1,065,540 |
| 2020-08-25 | KURA | Sale | 23,053 | 22.37 | 515,787 |
| 2020-08-24 | KURA | Sale | 6,568 | 22.04 | 144,771 |
| 2020-08-25 | KURA | Option Ex | 23,053 | 5.47 | 126,215 |
| 2020-08-24 | KURA | Option Ex | 6,568 | 4.80 | 31,526 |
| 2020-08-19 | KURA | Sale | 11,913 | 22.09 | 263,193 |
| 2020-08-18 | KURA | Sale | 521 | 22.00 | 11,462 |
| 2020-08-19 | KURA | Option Ex | 11,913 | 4.80 | 57,182 |
| 2020-08-17 | KURA | Sale | 62,901 | 22.00 | 1,383,947 |
| 2020-08-18 | KURA | Option Ex | 521 | 4.80 | 2,500 |
| 2020-08-17 | KURA | Option Ex | 12,901 | 4.80 | 61,924 |
| 2020-02-11 | KURA | Option Ex | 28,096 | 5.47 | 153,825 |
| 2018-11-06 | KURA | Option Ex | 26,041 | 4.80 | 124,996 |
| 2017-08-22 | KURA | Option Ex | 27,985 | 4.80 | 134,328 |
| 2017-04-21 | KURA | Option Ex | 5,000 | 4.80 | 24,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wilson Troy Edward
(President and CEO of Kura Oncology, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.